Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity

Otavio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, Paula Paccielli Freire, Igor Salerno Filgueiras, Israel Zyskind, Miriam T. Lattin, Florian Tran, Stefan Schreiber, Alexandre H.C. Marques, Desirée Rodrigues Plaça, Dennyson Leandro M. Fonseca, Jens Y. Humrich, Antje Müller, Lasse M. Giil, Hanna Graßhoff, Anja SchumannAlexander Hackel, Juliane Junker, Carlotta Meyer, Hans D. Ochs, Yael Bublil Lavi, Carmen Scheibenbogen, Ralf Dechend, Igor Jurisica, Kai Schulze-Forster, Jonathan I. Silverberg, Howard Amital, Jason Zimmerman, Harry Heidecke, Avi Z. Rosenberg, Gabriela Riemekasten, Yehuda Shoenfeld

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1220
JournalNature Communications
Volume13
Issue number1
DOIs
StatePublished - Mar 9 2022
Externally publishedYes

ASJC Scopus Subject Areas

  • General Chemistry
  • General Biochemistry,Genetics and Molecular Biology
  • General Physics and Astronomy

Keywords

  • Autoantibodies/blood
  • Autoimmunity
  • Severity of Illness Index
  • Multivariate Analysis
  • Cross-Sectional Studies
  • Humans
  • Male
  • COVID-19/blood
  • Receptors, CXCR3/immunology
  • Machine Learning
  • Receptors, G-Protein-Coupled/immunology
  • SARS-CoV-2
  • Biomarkers/blood
  • Female
  • Renin-Angiotensin System/immunology
  • Receptor, Angiotensin, Type 1/immunology

Cite this